The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing ...

Patsnap, a global leader in innovation and pharma intelligence, announced the launch of Hiro Life Sciences (Hiro LS), a groundbreaking AI assistant poised to redefine biopharmaceutical research and ...

The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.

Roche’s long-running bet on a new kind of cancer immunotherapy has, after years of shrinking optimism and second-guessing by ...

Linguistic validation goes beyond standard translation, bridging the gap between linguistic accuracy and cultural relevance,” comments Muntsa Cuchí , Life Sciences Sales Leader, Europe, at Welocalize.

The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the ...

Reduced Weight Regain: CCT-217 shows promise in preventing weight regain commonly observed after discontinuing incretin ...

Winrevair treats pulmonary arterial hypertension, a condition that makes pumping blood through the lungs harder and ...

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...

Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target ...

The restructuring follows the company's receipt of a letter from the FDA citing "deficiencies" in its approval application ...